Age: 47.0
Sex: M
Vaccine: FLUX
Symptoms: Chills, Malaise, Myopia, Pleural effusion, Vision blurred
Clinical narrative: patient reports he is also near sighted; sick; experienced fluid in his chest and chills; experienced fluid in his chest and chills; reports blurred vision; Initial information on 26-Dec-2024 regarding an unsolicited valid non-serious case received from a patient.  This case involves a 50-year-old male patient who was near sighted, sick, experienced fluid in his chest and chills and reports blurred vision while treated with DUPILUMAB [DUPIXENT] delivered via pre-filled syringe and after receiving influenza vaccine.   The patient's past medical history, medical treatment(s), concomitant(s) and family history were not provided. At the time of the event, the patient had ongoing Pre-diabetes.   On an unknown date in Sep-2021, the patient started taking DUPIXENT (DUPILUMAB) Solution for injection 600 mg 1X subcutaneously, strength: 300Mg/2ML followed by 300 mg QOW subcutaneously for Asthma and Nasal polyps via pre-filled syringe. On an unknown date in 2024, the patient received an unknown dose of influenza vaccine produced by unknown manufacturer (formulation, strength, expiry date and lot number not reported) via unknown route in unknown administration site as prophylactic vaccination (Immunization).  On an unknown date the patient developed a non-serious event "patient reports he is also near sighted" (myopia) (unknown latency) following the first dose intake (with an unknown batch number, expiry date) of DUPILUMAB and INFLUENZA VACCINE.  On an unknown date the patient developed a non-serious event "sick" (illness) (unknown latency) following the first dose intake (with an unknown batch number, expiry date) of DUPILUMAB and INFLUENZA VACCINE.  On an unknown date the patient developed a non-serious event "experienced fluid in his chest and chills" (pleural effusion), (chills) (unknown latency) following the first dose intake (with an unknown batch number, expiry date) of DUPILUMAB and INFLUENZA VACCINE.  On an unknown date the patient developed a non-serious event "reports blurred vision" (vision blurred) (unknown latency) following the first dose intake (with an unknown batch number, expiry date) of DUPILUMAB and INFLUENZA VACCINE. Information on batch number and expiration date corresponding to the one at time of event occurrence was requested.  It was reported "the patient he was diagnosed with pre -diabetes 2-3 years ago. he reports no change in his pre -diabetes symptoms since the start of therapy. patient reports blurred vision, onset 1-2 years ago. md not aware. patient reports he is also near sighted and wears reading glasses. patient reports getting sick after the influenza vaccine he received in the fall of 2024. he experienced fluid in his chest and chills. The (doctor of medicine) md prescribed an antibiotic."  Action taken: no action taken for all events for DUPILUMAB and not applicable for all events for influenza vaccine.  Corrective treatment: wears reading glasses for myopia; unspecified antibiotic for pleural effusion, chills and not reported for other events.  At time of reporting, the outcome was Unknown for all events.